Mini Bolus for Fluid Challenge Responsiveness in the Emergency Department
Launched by UNIVERSITY OF MONASTIR · May 5, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to help patients who are critically ill and experiencing low blood pressure, known as acute circulatory failure. Researchers want to find out if giving a small amount of fluid, called a mini-bolus (just 50 ml), can help predict how well a patient will respond to further fluid treatment. The goal is to improve care for those who are struggling to maintain stable blood pressure and proper blood flow.
To participate in this trial, patients need to be between the ages of 18 and 100, be breathing on their own, and have signs of acute circulatory failure, such as very low blood pressure or a high heart rate. However, individuals who are in very critical condition, have certain serious medical issues, or are pregnant cannot take part. If eligible, participants will receive the mini-bolus fluid challenge and be monitored to see how their body responds. This research could lead to better treatment strategies for patients in the emergency department.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with spontaneous breathing
- * Patients in whom a fluid challenge is indicated because they present acute circulatory failure (which is defined as systolic blood pressure less than 90 mmHg or the need for vasopressors (norepinephrine more than 0.1 µg/kg/min) to maintain a systolic blood pressure more than 90 mmHg (14), and at least one sign of inadequate tissue perfusion:
- • urine output of below 0.5ml/kg per hour over 1 hour
- • tachycardia (heart rate of greater than 100 beats per minute)
- • mottled skin.
- • lactate \> 2 mmol/l
- Exclusion Criteria:
- • Cardiac arrest
- • Acute respiratory distress syndrome
- • Coma Glasgow Scale \< 14
- • Age of less than 18 years
- • Moribund patients
- • Pregnant patients
- • impossibility to perform passive leg raising (PLR) (trauma patients, lower extremity amputees, and prone patients)
- • Patients with cardiac arrhythmias
- • Patients with cardiogenic pulmonary oedema
About University Of Monastir
The University of Monastir, a prominent educational and research institution in Tunisia, is dedicated to advancing medical and clinical research through its innovative programs and collaborations. With a strong emphasis on improving healthcare outcomes, the university actively sponsors clinical trials that explore new therapeutic approaches and enhance patient care. Leveraging its state-of-the-art facilities and a diverse team of experienced researchers and clinicians, the University of Monastir aims to contribute significantly to the global body of medical knowledge while fostering a culture of scientific inquiry and excellence.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Monastir, , Tunisia
Monastir, , Tunisia
Patients applied
Trial Officials
Semir Nouira, Prof
Principal Investigator
University Hospital Fattouma Bourguiba Monastir , Emergency Department .
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials